首页|纤维支气管镜肺泡灌洗术配合头孢哌酮舒巴坦治疗老年支气管扩张伴肺部感染的疗效及安全性分析

纤维支气管镜肺泡灌洗术配合头孢哌酮舒巴坦治疗老年支气管扩张伴肺部感染的疗效及安全性分析

扫码查看
目的 分析纤维支气管镜肺泡灌洗术(BAL)配合头孢哌酮舒巴坦在老年支气管扩张(BE)伴肺部感染患者中的应用效果.方法 选取 2022 年1 月—2023 年8 月该院收治的 60 例老年BE伴肺部感染患者为研究对象,按随机数字表法将其分为对照组和观察组,各30例.对照组采用头孢哌酮舒巴坦治疗,观察组加以BAL,持续治疗 2 周.对比两组临床疗效、症状改善情况、炎症因子水平、肺功能、不良反应发生情况.结果 观察组治疗总有效率为 93.33%,高于对照组的 73.33%,退热时间为(5.20±1.02)d,咳嗽消失时间为(5.16±1.34)d,肺部湿啰音消失时间为(7.35±1.63)d,均短于对照组的(6.79±1.53)d、(6.83±1.69)d、(9.76±2.05)d,组间差异有统计学意义(P<0.05).治疗后,观察组C反应蛋白为(11.39±1.05)mg/L,降钙素原为(0.12±0.01)ng/mL,均低于对照组的(15.56±2.13)mg/L、(0.21±0.04)ng/mL,最大通气量为(69.96±7.48)L,第1 秒最大呼气量为(2.26±0.84)L,肺活量为(2.98±0.71)L,均大于对照组的(61.47±6.20)L、(1.83±0.69)L、(2.54±0.63)L,组间差异有统计学意义(P<0.05).60 例患者治疗过程内均未出现不良反应.结论 BAL配合头孢哌酮舒巴坦可缓解老年BE伴肺部感染患者症状,减轻炎症反应,改善肺功能,存在一定的应用价值.
The Efficacy and Safety Analysis of Fiberoptic Bronchoscopy Combined with Bronchoalveolar Lavage and Cefoperazone Sulbactam in the Treatment of Elderly Patients with Bronchiectasis and Pulmonary Infection
Objective To analyze the effect of bronchoalveolar lavage(BAL)combined with cefoperazone sulbactam in elderly patients with bronchiectasis(BE)and pulmonary infection.Methods 60 elderly BE patients with pulmonary infection admitted to the hospital from January 2022 to August 2023 were selected as the research subjects.They were randomly divided into a control group and an observation group,with 30 cases in each group,using a random number table method.The control group received cefoperazone sulbactam,while the observation group received BAL and continued treatment for 2 weeks.Compare the clinical efficacy,symptom improvement,levels of inflammatory factors,lung function,and adverse reactions between two groups.Results The total effective rate of the observation group was 93.33%,which was higher than the control group's 73.33%,the fever relief time was(5.20±1.02)d,the cough disappearance time was(5.16±1.34)d,and the lung wet rale disappearance time was(7.35±1.63)d,which were shorter than the control group's(6.79±1.53)d,(6.83±1.69)d,and(9.76±2.05)d,and the differences between the groups were statistically significant(P<0.05).After treatment,the C-reactive protein was(11.39±1.05)mg/L,procalcitonin was(0.12±0.01)ng/mL,which was lower than the control group's(15.56±2.13)mg/L,(0.21±0.04)ng/mL,maximum ventilation volume was(69.96±7.48)L,maximum expiratory volume at 1 second was(2.26±0.84)L,lung capacity was(2.98±0.71)L,and which were greater than the control group's(61.47±6.20)L,(1.83±0.69)L,and(2.54±0.63)L,respectively,and the differences between the groups were statistically significant(P<0.05).No adverse reactions occurred during the treatment of 60 patients.Conclusion BAL combined with cefoperazone sulbactam can alleviate symptoms,alleviate inflammatory reactions,and improve lung function in elderly BE patients with pulmonary infection,and has certain application value.

BronchiectasiaPulmonary infectionAdverse reactionsPulmonary function

李静

展开 >

济宁市兖州区人民医院呼吸内科,山东济宁 272100

支气管扩张 肺部感染 不良反应 肺功能

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(4)
  • 10